Furthermore, we have shown that NP-G2-044 decreases the growth of U2932 and Ly10 cells (both are ABC-subtype of DLBCL cells) and HT cells (a diffuse mixed lymphoma cell), as well as MDA-MB-468 and BT-20 cells (both are EGFR-high triple-negative breast cancer cells). This evidence concerns the gene EGFR and triple-negative breast carcinoma.